Consistently, the genomes of BRCA1-mutant breast cancer patients show frequent insertions and deletions in R-loop-rich transcription termination regions [78], whereas these mutations appear throughout the genome in BRCA2-mutated breast cancers [78,82]. The gene discussed is BRCA1; the disease is breast carcinoma.